Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mel...
New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Paten...
New York, New York--(Newsfile Corp. - September 8, 2021) - AGENTIX Corp. (OTC Pink: AGTX), a pharmaceutical company focused on developing innovative therapeutic treatments targeting the endocannabinoid system (ECS) for the treatment of metabolic diseases, announced today it had entered into a ...
Phoenix, Arizona--(Newsfile Corp. - November 11, 2020) - The Stock Day Podcast welcomed Agentix Biopharma (OTC Pink: AGTX) ("the Company"), a biotechnology company focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS)...
News, Short Squeeze, Breakout and More Instantly...
Agentix Corp - Ordinary Shares Company Name:
AGTX Stock Symbol:
OTCMKTS Market:
Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mel...
New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Paten...
New York, New York--(Newsfile Corp. - September 8, 2021) - AGENTIX Corp. (OTC Pink: AGTX), a pharmaceutical company focused on developing innovative therapeutic treatments targeting the endocannabinoid system (ECS) for the treatment of metabolic diseases, announced today it had entered into a ...